Malignant lymphomas

Patients with symptomatic advanced* follicular lymphoma and Diffuse Large B Cell Lymphoma (DLBCL) should undergo treatment with anti-B cell monoclonal antibody therapy At time of publication, rituximab is the only anti-B cell … ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download